Peptinovo Biopharma: Partnerships and Licensing

Partnership and licensing opportunities from Peptinovo Biopharma.

 

Partnership Title: Our proprietary PALM™ technology delivers proven chemotherapies directly to tumors while reducing toxicity to healthy tissues

Peptinovo Biopharma is a privately held biotechnology company based in Ann Arbor, Michigan, developing next-generation targeted nanomedicines to enhance the treatment of cancer. Its proprietary PALM™ technology delivers proven chemotherapies directly to tumors while reducing toxicity to healthy tissues, aiming to improve outcomes and quality of life for patients. The company has raised $16.8M to date and is raising additional funds in its current Series A round to expand development of its platform. Peptinovo is reaching a significant inflection point at a very attractive valuation

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.

• Research and Development
  We offer co-development opportunities.

• Biopharmaceuticals
  - Biopharmaceuticals-Development Platforms

• Antineoplastic and Immunomodulating Agents
  - Anti-neoplastic agents
  - Immuno-oncology

Claim This Profile

This is the Partnership and Licensing section of the company profile page for Peptinovo Biopharma on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.